Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Zoetis Inc. (ZTS) Form 8-K — Aug 6, 2026

$ZTSForm 8-KItems 5.02, 9.01Filed Aug 6, 2026, 4:17 PM ET0001193125-26-338080Original filing

Zoetis announced on August 6, 2026 that James (Jay) Saccaro has been appointed Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. It is a newly created role combining leadership of the global finance function with oversight of Global Manufacturing and Supply. Saccaro, 53, has served as Vice President and CFO of GE HealthCare Technologies since June 2023 and previously spent roughly eight years as EVP and CFO of Baxter International (July 2015 to May 2023), giving Zoetis a successor with about 12 years of CFO experience at large healthcare companies.

Key figures

Saccaro base salary
1000000
Saccaro target bonus
100% of base salary (2026 bonus guaranteed at target, pro-rated)
Make whole cash award
1250000
Joseph advisor through
February 28, 2027 or earlier mutually agreed date
Joseph noncompete period
12 months following termination date
Appointment effective date
August 17, 2026
Make whole rsu grant value
6250000
Saccaro annual ltip target
5000000

Price after filing

1 day: -2.2%7 days: -0.3%30 days: -0.3%

Close on the filing date to close N calendar days later (from $76.04). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.